Cancer Archives | Page 2 of 213

ALL CANCER NEWS

The American Cancer Society and Anthem Foundation Team to Expand Health Equity in At-Risk Communities

April 15, 2021

Study finds risk-causing genetic changes in nearly 1 in 6 patients with colorectal cancer

April 15, 2021

BioLineRx Announces Presentation at 2021 American Association for Cancer Research (AACR) Annual Meeting

April 15, 2021

Late-Breaking New Independent Validation Study of 1,674 Patients Demonstrates Castle Biosciences’ i31-GEP Artificial Intelligence Algorithm Improves Precision of Sentinel Lymph Node Positivity Prediction in Cutaneous Melanoma

April 15, 2021

Adlai Nortye Announces First Patient Dosed in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

April 14, 2021

Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cabometyx® (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma

April 14, 2021

StemSynergy Therapeutics’ Notch1-Selective Small Molecule Inhibitor Prevents Tumor Growth by Ablation of Cancer Stem Cells

April 14, 2021

Cancer Support Community Supports Brooks-LaSure Nomination for CMS Administrator

April 14, 2021

Global Multiple Myeloma Disease Coverage Forecast and Market Analysis 2021-2027: Key Upcoming Events for 2021 Include the Expected US Approval of the BCMA-directed CAR-T Therapies ide-cel and JNJ-4528

April 14, 2021

NOXXON Successfully Completes Patient Recruitment in Phase 1/2 Brain Cancer Study of NOX-A12 Plus Radiotherapy

April 14, 2021

Protein Found to Control Drivers of Normal Growth and Cancer

April 14, 2021

TriSalus Life Sciences Presents Data at American Association of Cancer Research Showing Reduced Liver Tumor Burden from Toll-Like Receptor Agonists

April 14, 2021

Everest Medicines Announces that the US FDA has Granted Licensing Partner Gilead Sciences, Inc. Accelerated Approval of Trodelvy® for the Treatment of Metastatic Urothelial Cancer

April 14, 2021

Oncocyte Hosting Key Opinion Leader Call on Novel Biomarkers in Identifying Appropriate Responders to Immune Checkpoint Inhibitors

April 14, 2021

Boehringer Ingelheim and MD Anderson Expand Collaboration to Accelerate Development of KRAS and TRAILR2 Compounds in Lung Cancer

April 14, 2021

Third Virtual Forum to Address Racial Disparities in Breast Cancer Survivorship

April 14, 2021

Agenus Doses First Cancer Patient with iNKT Cell Therapy

April 14, 2021

Study from Inspire reveals COVID-19 vaccine hesitancy among individuals with cancer, autoimmune diseases and other serious comorbidities

April 14, 2021

Veracyte Announces Key Milestone in Companion Diagnostics Program With Acerta Pharma Using LymphMark Lymphoma Subtyping Test

April 14, 2021

Tango Therapeutics and BCTG Acquisition Corp. Announce Merger Agreement to Create Publicly Listed Precision Medicine Company Focused on the Next Generation of Targeted Cancer Therapies

April 14, 2021

ALL CANCER NEWS

The American Cancer Society and Anthem Foundation Team to Expand Health Equity in At-Risk Communities

Study finds risk-causing genetic changes in nearly 1 in 6 patients with colorectal cancer

BioLineRx Announces Presentation at 2021 American Association for Cancer Research (AACR) Annual Meeting

Late-Breaking New Independent Validation Study of 1,674 Patients Demonstrates Castle Biosciences’ i31-GEP Artificial Intelligence Algorithm Improves Precision of Sentinel Lymph Node Positivity Prediction in Cutaneous Melanoma

Adlai Nortye Announces First Patient Dosed in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cabometyx® (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma

StemSynergy Therapeutics’ Notch1-Selective Small Molecule Inhibitor Prevents Tumor Growth by Ablation of Cancer Stem Cells

Cancer Support Community Supports Brooks-LaSure Nomination for CMS Administrator

Global Multiple Myeloma Disease Coverage Forecast and Market Analysis 2021-2027: Key Upcoming Events for 2021 Include the Expected US Approval of the BCMA-directed CAR-T Therapies ide-cel and JNJ-4528

NOXXON Successfully Completes Patient Recruitment in Phase 1/2 Brain Cancer Study of NOX-A12 Plus Radiotherapy

Protein Found to Control Drivers of Normal Growth and Cancer

TriSalus Life Sciences Presents Data at American Association of Cancer Research Showing Reduced Liver Tumor Burden from Toll-Like Receptor Agonists

Everest Medicines Announces that the US FDA has Granted Licensing Partner Gilead Sciences, Inc. Accelerated Approval of Trodelvy® for the Treatment of Metastatic Urothelial Cancer

Oncocyte Hosting Key Opinion Leader Call on Novel Biomarkers in Identifying Appropriate Responders to Immune Checkpoint Inhibitors

Boehringer Ingelheim and MD Anderson Expand Collaboration to Accelerate Development of KRAS and TRAILR2 Compounds in Lung Cancer

Third Virtual Forum to Address Racial Disparities in Breast Cancer Survivorship

Agenus Doses First Cancer Patient with iNKT Cell Therapy

Study from Inspire reveals COVID-19 vaccine hesitancy among individuals with cancer, autoimmune diseases and other serious comorbidities

Veracyte Announces Key Milestone in Companion Diagnostics Program With Acerta Pharma Using LymphMark Lymphoma Subtyping Test

Tango Therapeutics and BCTG Acquisition Corp. Announce Merger Agreement to Create Publicly Listed Precision Medicine Company Focused on the Next Generation of Targeted Cancer Therapies

Subscribe to our daily newsletters

Follow us on